Barriers and Facilitators to Staying Smoke-Free after Having a Baby, a Qualitative Study: Women's Views on Support Needed to Prevent Returning to Smoking Postpartum.


Journal

International journal of environmental research and public health
ISSN: 1660-4601
Titre abrégé: Int J Environ Res Public Health
Pays: Switzerland
ID NLM: 101238455

Informations de publication

Date de publication:
28 10 2021
Historique:
received: 23 09 2021
revised: 25 10 2021
accepted: 26 10 2021
entrez: 13 11 2021
pubmed: 14 11 2021
medline: 20 11 2021
Statut: epublish

Résumé

Postpartum return to smoking (PPRS) is a common and important public health problem. Interventions to prevent PPRS have not been shown to be effective. We aimed to qualitatively explore the barriers and facilitators to staying smoke-free after having a baby, and women's views on the support needed to avoid PPRS to inform future intervention development. We conducted semi-structured telephone interviews ( Five overarching themes were identified: (i) smoking intentions; (ii) facilitators to staying smoke-free; (iii) barriers to staying smoke-free; (iv) support to avoid relapse; and (v) e-cigarettes, nicotine replacement therapy, and varenicline. Facilitators to staying smoke-free were the health benefits to their baby, whilst barriers included stress, cravings, and being in environments where they would previously have smoked. Women wanted continuous offers of support to stay smoke-free throughout the extended postpartum period, with a particular interest in support for partners to quit smoking and self-help support. Women expressed safety concerns for e-cigarettes, nicotine replacement therapy, and varenicline. Offers of support to stay smoke-free should continue throughout the postpartum and engage with partners or other household members who smoke. Reassuring women about the relative safety of nicotine replacement therapy and e-cigarettes by a health professional, particularly for those who are breastfeeding, could be beneficial.

Sections du résumé

BACKGROUND
Postpartum return to smoking (PPRS) is a common and important public health problem. Interventions to prevent PPRS have not been shown to be effective. We aimed to qualitatively explore the barriers and facilitators to staying smoke-free after having a baby, and women's views on the support needed to avoid PPRS to inform future intervention development.
METHODS
We conducted semi-structured telephone interviews (
RESULTS
Five overarching themes were identified: (i) smoking intentions; (ii) facilitators to staying smoke-free; (iii) barriers to staying smoke-free; (iv) support to avoid relapse; and (v) e-cigarettes, nicotine replacement therapy, and varenicline. Facilitators to staying smoke-free were the health benefits to their baby, whilst barriers included stress, cravings, and being in environments where they would previously have smoked. Women wanted continuous offers of support to stay smoke-free throughout the extended postpartum period, with a particular interest in support for partners to quit smoking and self-help support. Women expressed safety concerns for e-cigarettes, nicotine replacement therapy, and varenicline.
CONCLUSIONS
Offers of support to stay smoke-free should continue throughout the postpartum and engage with partners or other household members who smoke. Reassuring women about the relative safety of nicotine replacement therapy and e-cigarettes by a health professional, particularly for those who are breastfeeding, could be beneficial.

Identifiants

pubmed: 34769875
pii: ijerph182111358
doi: 10.3390/ijerph182111358
pmc: PMC8583693
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Références

Matern Child Health J. 2009 Nov;13(6):865-72
pubmed: 18818994
Addiction. 2018 Apr;113(4):610-622
pubmed: 29235189
Nicotine Tob Res. 2020 Jun 12;22(7):1178-1186
pubmed: 31570944
BJOG. 2021 May;128(6):984-993
pubmed: 33012050
Health Technol Assess. 2010 Oct;14(49):1-152, iii-iv
pubmed: 21040645
Cochrane Database Syst Rev. 2020 May 22;5:CD013629
pubmed: 32441810
Thorax. 2011 Oct;66(10):847-55
pubmed: 21325144
Addiction. 2008 Apr;103(4):566-79
pubmed: 18339103
Cochrane Database Syst Rev. 2017 Feb 14;2:CD001055
pubmed: 28196405
Addiction. 2001 Mar;96(3):485-94
pubmed: 11255587
BMJ Open. 2014 May 14;4(5):e004915
pubmed: 24833689
Aust N Z J Obstet Gynaecol. 2008 Jun;48(3):280-5
pubmed: 18532959
Addiction. 2010 Mar;105(3):543-53
pubmed: 20402999
Addiction. 2015 Nov;110(11):1712-23
pubmed: 26355895
Addiction. 2010 Aug;105(8):1362-80
pubmed: 20653619
Matern Child Health J. 2008 Jul;12(4):525-33
pubmed: 17680214
Addiction. 2011 Oct;106(10):1819-26
pubmed: 21561499
Nicotine Tob Res. 2018 May 3;20(6):665-673
pubmed: 29065203
Addict Behav. 2019 May;92:236-243
pubmed: 30731328
Nicotine Tob Res. 2012 Jul;14(7):767-76
pubmed: 22180588
Am J Health Behav. 2008 May-Jun;32(3):272-82
pubmed: 18067467
Cochrane Database Syst Rev. 2019 Oct 28;2019(10):
pubmed: 31684681
Addiction. 2016 Jun;111(6):981-90
pubmed: 26990248
BMJ Open. 2017 Nov 15;7(11):e018746
pubmed: 29146659
Int J Environ Res Public Health. 2019 Jun 03;16(11):
pubmed: 31163663
Cochrane Database Syst Rev. 2020 Mar 4;3:CD010078
pubmed: 32129504

Auteurs

Lucy Phillips (L)

School of Medicine, University of Nottingham, Nottingham NG7 2RD, UK.

Katarzyna Anna Campbell (KA)

School of Medicine, University of Nottingham, Nottingham NG7 2RD, UK.

Tim Coleman (T)

School of Medicine, University of Nottingham, Nottingham NG7 2RD, UK.

Michael Ussher (M)

Population Health Research Institute, St. George's University of London, London SW17 0RE, UK.
Institute for Social Marketing and Health, University of Stirling, Stirling FK9 4LA, UK.

Sue Cooper (S)

School of Medicine, University of Nottingham, Nottingham NG7 2RD, UK.

Sarah Lewis (S)

School of Medicine, University of Nottingham, Nottingham NG7 2RD, UK.

Sophie Orton (S)

School of Medicine, University of Nottingham, Nottingham NG7 2RD, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH